<SEC-DOCUMENT>0001728117-20-000008.txt : 20201110
<SEC-HEADER>0001728117-20-000008.hdr.sgml : 20201110
<ACCEPTANCE-DATETIME>20201110161417
ACCESSION NUMBER:		0001728117-20-000008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20201110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201110
DATE AS OF CHANGE:		20201110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gossamer Bio, Inc.
		CENTRAL INDEX KEY:			0001728117
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				475461709
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38796
		FILM NUMBER:		201301278

	BUSINESS ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 922-0718

	MAIL ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>goss-20201110.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1,d:9ad77ae211234e36bac64f9e20f7441a--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>goss-20201110</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV81MC9mcmFnOmU3YTJlMGViN2E2YjQxY2FiNjg2MGYzOTVjZTNhZmQ2L3RhYmxlOjljZmI5ZjFmNzU2YTRmNWU4NjVmNmU5Njk1OTRmYzhmL3RhYmxlcmFuZ2U6OWNmYjlmMWY3NTZhNGY1ZTg2NWY2ZTk2OTU5NGZjOGZfMC0xLTEtMS0xNTI_732a8b94-b7c2-431c-9465-c961b8849cb7">0001728117</ix:nonNumeric><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV81MC9mcmFnOmU3YTJlMGViN2E2YjQxY2FiNjg2MGYzOTVjZTNhZmQ2L3RhYmxlOjljZmI5ZjFmNzU2YTRmNWU4NjVmNmU5Njk1OTRmYzhmL3RhYmxlcmFuZ2U6OWNmYjlmMWY3NTZhNGY1ZTg2NWY2ZTk2OTU5NGZjOGZfMS0xLTEtMS0xNTU_69d08ea3-2542-4a1e-8fdf-131eb94ce770">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="goss-20201110.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-09</xbrli:startDate><xbrli:endDate>2020-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9ad77ae211234e36bac64f9e20f7441a_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTEz_3f4b39bb-05a8-4269-8e2b-c8caa99090c0">8-K</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTE1_a32a1ed4-45f1-47c5-9eaa-0080359f8e86">November 10, 2020</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMx_524e3695-560c-4c89-bffc-50823f7726e6">GOSSAMER BIO, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTAtMS0xLTkx_cb76d5a8-340a-46e3-be8a-dfcbd747c096">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTEtMS0xLTk0_0ef0e9a7-ffdf-4e6b-b54f-5a3618f843fd">001-38796</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTItMS0xLTk2_17187a75-63ea-423d-993c-b6a13d4b0257">47-5461709</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMy_13d79edc-86d7-4886-a730-affb7d07c04d">3013 Science Park Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMz_d84a3887-857d-417e-8709-23fa297b9b01">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTM0_9419ca49-da9b-41d6-acaf-3b8e98a32f0c">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTM2_230beacf-a443-4cab-a5a4-a969cb2eb109">92121</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTQz_9ffdd59c-a411-4255-bd2b-037a6f4e8ec5">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTcx_b141f880-99d9-4f56-847e-63d70c633800">684-1300</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6YzVlYzg3YzU2N2Q2NDNjNWE2MDJmYmUyYWU5MmM0ZGMvdGFibGVyYW5nZTpjNWVjODdjNTY3ZDY0M2M1YTYwMmZiZTJhZTkyYzRkY18wLTAtMS0xLTExNA_ead80fee-2b6c-4ccd-be8e-5bfb7a43c384">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6NmYxZjAxNzg5ODIzNDMzZWEyY2RjZDI5YTkxNDU3M2YvdGFibGVyYW5nZTo2ZjFmMDE3ODk4MjM0MzNlYTJjZGNkMjlhOTE0NTczZl8wLTAtMS0xLTExNw_8da1d166-26e7-4a93-b80a-4643a54fe7d8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmZhNDY1NzA2M2E4NDY5OWFlNDI1N2IzNzEwODc4OWIvdGFibGVyYW5nZTpmZmE0NjU3MDYzYTg0Njk5YWU0MjU3YjM3MTA4Nzg5Yl8wLTAtMS0xLTEyMA_e51dbc15-7b3c-4add-997c-f387eb96906f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6YWVjMzRjZmIyNDIxNDk2YjhjYTQ2MzVmNzFlMmMyODIvdGFibGVyYW5nZTphZWMzNGNmYjI0MjE0OTZiOGNhNDYzNWY3MWUyYzI4Ml8wLTAtMS0xLTEyMw_0d85318b-b4ca-43b4-8a71-3b710a9407a7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTAtMS0xLTEyNg_0da22225-9422-4072-a428-b97ba6427892">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTItMS0xLTEyOQ_e8bffd47-81c0-4442-ba46-c09e03ea6c96">GOSS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTQtMS0xLTEzMQ_6417ba21-302f-48f5-987e-0425cac06b62">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;<ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTYw_602ed389-a88b-4fb8-9cd7-c4d5accc3e4d">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<ix:nonNumeric contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTYx_54e2884b-2212-4cb3-a4d3-b942c21983ed">&#9746;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2020, Gossamer Bio, Inc. (the &#8220;Company&#8221;) issued a press release reporting its financial results for the quarter ended September 30, 2020.&#160;The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with General Instruction B.2 of Form 8-K, the information contained or incorporated herein, including the press release attached as Exhibit&#160;99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, whether made before or after the date hereof, except as&#160;expressly set forth by specific reference in such filing to this Current Report on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20201110xexx991.htm">Press Release dated November 10, 2020</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOSSAMER BIO, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 10, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>goss-20201110xexx991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i1f47ea31f6094d81a8d37ce4fad85af9_1"></div><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:center"><font><br></font></div><div><img alt="gossamer1a.jpg" src="gossamer1a.jpg" style="height:64px;width:151px"></div><div style="text-align:center"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- GB004&#58; SHIFT-UC Phase 2 trial enrolling patients with active ulcerative colitis (UC) -</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- GB002&#58; </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">TORREY Phase 2 trial activated in patients with pulmonary arterial hypertension (PAH) -</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- GB1275&#58; Two posters with data from ongoing Phase 1&#47;2 KEYNOTE-A36 clinical trial in advanced solid tumors presented at Society for Immunotherapy of Cancer Meeting 2020 - </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- GB001&#58; Engaging with global regulatory authorities about forward clinical development path for an oral DP2 antagonist in moderate-to-severe asthma -</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- Cash, cash equivalents and marketable securities totaled $555 million as of September 30, 2020 -</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SAN DIEGO &#8212; (BUSINESS WIRE) &#8212; November 10, 2020 &#8212; </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Gossamer Bio, Inc</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Nasdaq&#58; GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the third quarter of 2020 and provided a corporate update.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;We are very excited about the continued advancement of our pipeline with the start of two robust Phase 2 clinical trials for GB002 and GB004 and the planned dose expansion cohort for GB1275,&#8221;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">said Sheila Gujrathi, M.D., Co-Founder and Chief Executive Officer of Gossamer. &#8220;We believe that these clinical programs hold tremendous potential to benefit high unmet need patient populations.&#8221; </font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Clinical-Stage Product Candidate Updates</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GB002&#58; Inhaled PDGFR Inhibitor for Pulmonary Arterial Hypertension (PAH)</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">GB002 is currently being evaluated in an ongoing Phase 1b trial in PAH. Gossamer will discuss the initial results from this ongoing trial at as part of a GB002-focused investor webinar in December 2020. </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Sites activated in the TORREY Study, a 24-week Phase 2 clinical trial in functional class II and III PAH </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">patients. Gossamer expects to begin enrollment for this trial in the fourth quarter of 2020.</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The primary endpoint is change in pulmonary vascular resistance (PVR) from baseline at week 24. Topline data from the TORREY study are expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GB004&#58; Oral HIF-1&#945; Stabilizer for Inflammatory Bowel Disease</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Several patients dosed in the SHIFT-UC Study, a Phase 2 clinical trial in UC patients. The primary endpoint is proportion of patients with clinical remission at week 12. Topline data from the SHIFT-UC study are expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic.</font></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Data presented from completed Phase 1b study in patients with active mild-to-moderate ulcerative colitis (UC) at UEG Week Virtual 2020. These posters and presentations are available at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.gossamerbio.com</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on the &#8220;Posters and Publications&#8221; page.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GB1275&#58; Oral CD11b Modulator for Oncology Indications</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Two GB1275 posters are being presented at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2020), being held virtually from November 9 - 14. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This includes clinical and biomarker data from the ongoing GB1275 Phase 1&#47;2 clinical trial, KEYNOTE-A36, in advanced solid tumors and corresponding presentations from Johanna Bendell, M.D. and Wells Messersmith, M.D.</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.75pt">Poster Title&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Poster &#47; Abstract Number&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> 388 </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presenting Author&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Johanna Bendell, M.D. </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Link&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;goss.bio&#47;35CX8Rl</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.75pt">Poster Title&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Poster &#47; Abstract Number&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> 389 </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presenting Author&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Wells Messersmith, M.D.</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Link&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;goss.bio&#47;3mlGsEQ</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Encouraging biological activity, particularly at GB1275 doses greater than or equal to 800 mg BID, was seen in tumor types that are known to be less responsive to checkpoint inhibitors. This activity supports the mechanism of action of GB1275 in modulating myeloid cell biology in the tumor microenvironment, with potential to enhance anti-tumor response when it is combined with a checkpoint inhibitor.</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Prolonged stable disease has been observed in seven patients, in both the monotherapy and combination dose groups. Five of seven patients with observed prolonged stable disease received doses of 800mg BID or higher of GB1275.</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">One microsatellite stable-colorectal cancer patient receiving oral GB1275 800 mg twice daily, in combination with pembrolizumab, achieved a partial response. The patient had received five lines of therapy prior to trial enrollment and is continuing on study treatment. </font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Clinical safety data to date suggest that GB1275 alone and combined with pembrolizumab (up to 1200 mg twice daily) is generally well tolerated, and the maximum tolerated dose of GB1275 has not been reached.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GB001&#58; Oral DP2 Antagonist for Moderate-to-Severe Asthma</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">Engaging with global regulatory authorities regarding the forward clinical development path of an oral DP2 antagonist in moderate-to-severe asthma to inform potential partnerships or strategic alternatives.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Results for the Quarter Ended September 30, 2020</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.8pt">Cash, Cash Equivalents and Marketable Securities</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Cash, cash equivalents and marketable securities as of September 30, 2020, were $555.4 million. The Company expects the combination of current cash, cash equivalents and marketable securities, and access to its debt facility will be sufficient to fund its operating and capital expenditures into the second half of 2023.</font></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.8pt">Research and Development (R&#38;D) Expenses</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; For the quarter ended September 30, 2020, R&#38;D expenses were $41.8 million, compared to R&#38;D expenses of $40.1 million for the same period in 2019. </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.8pt">General and Administrative (G&#38;A) Expenses</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; For the quarter ended September 30, 2020, G&#38;A expenses were $11.4 million, compared to $9.8 million for the same period in 2019. </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:13.8pt">Net Loss</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Net loss for the quarter ended September 30, 2020, was $57.8 million, or $0.80 or share, compared to a net loss of $48.5 million, or $0.80 per share, for the same period in 2019.  The increase was primarily attributable to an increase in interest expense of $4.0 million and a decrease in investment income of $1.7 million.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call and Webcast</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Gossamer&#8217;s management team will host a conference call and live audio webcast at 4&#58;30 p.m. ET today, Tuesday, November 10, to discuss its third quarter 2020 financial results and provide a corporate update.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The live audio webcast may be accessed through the &#8220;Events &#47; Presentations&#8221; page in the &#8220;Investors&#8221; section of the Company's website at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.gossamerbio.com</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Alternatively, the conference call may be accessed through the following&#58;</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Conference ID&#58; </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2879501</font></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Domestic Dial-in Number&#58; </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(833) 646-0603</font></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">International Dial-in Number&#58; </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(929) 517-9782  </font></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Live Webcast&#58; </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">https&#58;&#47;&#47;edge.media-server.com&#47;mmc&#47;p&#47;e6ppaa7u</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A replay of the audio webcast will be available for 30 days on the &#8220;Investors&#8221; section of the Company's website, </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.gossamerbio.com</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Gossamer Bio</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Gossamer cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on the Company&#8217;s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding&#58; the anticipated timing of initiation and enrollment of clinical trials for our product candidates&#59; plans to advance our product candidates&#59; expectations on the timing of data readouts from our clinical studies&#59; the potential clinical benefits, safety profile and market potential of our product candidates&#59; the potential of our product candidates to benefit high unmet need patient populations&#59; the expected impact of COVID-19&#59; our plans to discuss the results of the recent Phase 2b study of GB001 in asthma with global regulatory authorities to inform potential partnerships or strategic alternatives&#59; and the expected timeframe for funding our operating plan with current cash, cash equivalents and marketable securities. The inclusion of forward-looking statements should not be regarded as a representation by Gossamer that any of its plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Gossamer&#8217;s business, including, without limitation&#58; potential delays in the commencement, enrollment and completion of clinical trials&#59; disruption to our operations from the recent global outbreak of the COVID-19 pandemic, including clinical trial delays&#59; the Company&#8217;s dependence on third parties in connection with product manufacturing, research and preclinical and clinical testing&#59; the results of preclinical studies and early clinical trials are not necessarily predictive of future results&#59; the success of Gossamer&#8217;s clinical trials and preclinical studies for its product candidates&#59; interim results do not necessarily predict final results and one or more of the outcomes may materially change  as the trial continues and more patient data become available and following more comprehensive audit and verification procedures&#59; Gossamer may not proceed into Phase 3 clinical trials for GB001, including because the Phase 2b study results in asthma may not support continued clinical development of GB001&#59;  regulatory developments in the United States and foreign countries&#59; unexpected adverse side effects or inadequate efficacy of our product candidates that may limit their development, regulatory approval and&#47;or commercialization, or may result in recalls or product liability claims&#59; Gossamer&#8217;s ability to obtain and maintain intellectual property protection for its product candidates&#59; Gossamer&#8217;s ability to comply with its obligations in collaboration agreements with third parties or the agreements under which it licenses intellectual property rights from third parties&#59; Gossamer may use its capital resources sooner than it expects&#59; and other risks described in the Company&#8217;s prior press releases and the Company&#8217;s filings with the Securities and Exchange Commission (SEC), including under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Gossamer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Gossamer Bio Statement of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statement of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.552%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STATEMENTS OF OPERATIONS DATA&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,148&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,944&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,807&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development</font></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">275&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,080&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,448&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,838&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,851&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,544&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</font></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,569&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,986&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,875&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,351&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(53,569)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(49,986)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(173,875)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(130,351)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</font></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,243)</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,881)</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,742&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(57,812)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(48,500)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(178,756)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(125,609)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.80)</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.80)</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.67)</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.39)</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding, basic and diluted</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72,245,897&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,755,872&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,931,512&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,535,569&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheet</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE SHEET DATA&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2019</font></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and marketable securities</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555,378&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,829&#160;</font></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533,599&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,394&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,178&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426,604&#160;</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,077&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,119&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512,926)</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334,170)</font></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,101&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,485&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:115%">For Investors and Media&#58;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Bryan Giraudo, Chief Financial Officer</font></div><div><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Gossamer Bio Investor Relations</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">ir&#64;gossamerbio.com</font></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>goss-20201110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:goss="http://www.gossamerbio.com/20201110" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gossamerbio.com/20201110">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20201110_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20201110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20201110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20201110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.gossamerbio.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>goss-20201110_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20201110.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>goss-20201110_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20201110.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended" id="i92165b45a55946bdb511c811ca2b9f21_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>goss-20201110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_b27a8670-8968-4f90-8ced-475c939a05c4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_12068f71-b0b3-4590-9c11-fe8051a918dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_50681bb5-8867-4c0b-8155-743e76013215_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_be5c612d-5574-49d5-9431-572c48620558_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_13c05ff1-a69d-4033-a1e4-c7a1c925f6d7_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_75032234-4664-4f41-8769-a68265af7b98_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2e348b9b-5521-4d1a-85aa-65edfc18a921_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a95190ae-ce22-4a2d-bacf-70e7eb12997a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7943b910-882b-494a-9ab7-996e44dfefd8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_19979930-6b7e-4c64-b6c3-923eed588bbb_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2eb24e6c-0398-497e-b802-305f73cc8c77_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d5f44fa6-bd57-4822-9c42-d060615c543a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_60395a2e-cb67-4164-b1dd-c169bd28a0b0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b009ddf5-a67e-4d7c-ad0a-a4442aae7a12_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ed446b2d-4876-406b-b859-a1aa733bcf47_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_05ab70fa-6e19-40df-955a-d61364afa9db_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ad09922c-d98f-4b87-9741-6bd1e15558ce_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6d2e175e-6127-463f-b681-c929e7773d24_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b80248f1-26cb-4935-ac98-a39adf1df972_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2ee3ada0-3563-4e25-8dd0-f8f88b9ce9bb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3be89fb1-47e8-46e3-9923-edf2116216bc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_50712cf1-458b-4b66-b2cf-b54cc4385322_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_534b4f6b-ed33-4b8c-b064-51b6e503af6e_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>goss-20201110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:070ccaf5-eccf-4bdf-a072-6a52fb4ec5f9,g:ed87d640-b69b-44eb-b0cf-2665aa614fe1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20201110.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d96ab789-d42a-4021-b052-c950b2cdbe70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_DocumentType_d96ab789-d42a-4021-b052-c950b2cdbe70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f648ff4c-6e80-4ece-ae20-b34098958581" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_DocumentPeriodEndDate_f648ff4c-6e80-4ece-ae20-b34098958581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_791406bc-8009-4cc8-97cb-8d210986d796" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityRegistrantName_791406bc-8009-4cc8-97cb-8d210986d796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_21528f8d-d9f8-4ff5-a8cc-837aa0cbca88" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_21528f8d-d9f8-4ff5-a8cc-837aa0cbca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_09f0fc27-7d46-4f51-a7e5-a84515ea72ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityFileNumber_09f0fc27-7d46-4f51-a7e5-a84515ea72ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c6353611-e4a5-440d-80ec-933c75b7970b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityTaxIdentificationNumber_c6353611-e4a5-440d-80ec-933c75b7970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_49ef711d-0ecb-44b8-816b-cc5e36d4830c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityAddressAddressLine1_49ef711d-0ecb-44b8-816b-cc5e36d4830c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ad3bfce1-4d90-4645-979d-7c10857b6e5e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityAddressCityOrTown_ad3bfce1-4d90-4645-979d-7c10857b6e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7b61ceb5-f642-41e7-a86c-345f91f7ccc2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityAddressStateOrProvince_7b61ceb5-f642-41e7-a86c-345f91f7ccc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_68ebbd34-c7cc-486f-bb3d-cf099463d3df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityAddressPostalZipCode_68ebbd34-c7cc-486f-bb3d-cf099463d3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_47d095ca-4cb7-4e5a-b453-cbbf80e5a372" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_CityAreaCode_47d095ca-4cb7-4e5a-b453-cbbf80e5a372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_baa5051e-da68-4b6a-8c9b-31afb628b3ae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_LocalPhoneNumber_baa5051e-da68-4b6a-8c9b-31afb628b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d575542e-151c-46c7-b232-222f04500925" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_WrittenCommunications_d575542e-151c-46c7-b232-222f04500925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f0f156f7-d036-4dc4-904b-3427939b694e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_SolicitingMaterial_f0f156f7-d036-4dc4-904b-3427939b694e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_ffed006e-f99b-4e71-ab9c-6cf7ee0c2986" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_PreCommencementTenderOffer_ffed006e-f99b-4e71-ab9c-6cf7ee0c2986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_52246316-9513-4cda-b103-ef0f5d0d4ff0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_52246316-9513-4cda-b103-ef0f5d0d4ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7c1433e4-f416-4f6b-b762-cf0338c23d93" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_Security12bTitle_7c1433e4-f416-4f6b-b762-cf0338c23d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_67ec54ea-994d-42b4-94f0-b5671e3c3062" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_TradingSymbol_67ec54ea-994d-42b4-94f0-b5671e3c3062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8275e94c-5244-4855-af71-14ba532d7036" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_SecurityExchangeName_8275e94c-5244-4855-af71-14ba532d7036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e793f5a7-dc25-47df-9167-e58451ce741a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityEmergingGrowthCompany_e793f5a7-dc25-47df-9167-e58451ce741a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_117ab6ab-02a5-41bd-a256-c19b730c1200" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityExTransitionPeriod_117ab6ab-02a5-41bd-a256-c19b730c1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e60bd4ef-0503-4602-898b-2f75f9f17bf3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_EntityCentralIndexKey_e60bd4ef-0503-4602-898b-2f75f9f17bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_795e78da-50d0-4f4e-a0b1-a6ff782eb5e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd0440ca-7486-4779-a63e-e0babd6e45d1" xlink:to="loc_dei_AmendmentFlag_795e78da-50d0-4f4e-a0b1-a6ff782eb5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gossamer1a.jpg
<TEXT>
begin 644 gossamer1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( *H# 2(  A$! Q$!_\0
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M#^E$>K6<L,LJR'9$P1LJ<[B!\N.N><8ZYH O451;46B3S9K*YCAZER%.T>I
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>goss-20201110_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="goss-20201110.xsd" xlink:type="simple"/>
    <context id="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-11-09</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV81MC9mcmFnOmU3YTJlMGViN2E2YjQxY2FiNjg2MGYzOTVjZTNhZmQ2L3RhYmxlOjljZmI5ZjFmNzU2YTRmNWU4NjVmNmU5Njk1OTRmYzhmL3RhYmxlcmFuZ2U6OWNmYjlmMWY3NTZhNGY1ZTg2NWY2ZTk2OTU5NGZjOGZfMC0xLTEtMS0xNTI_732a8b94-b7c2-431c-9465-c961b8849cb7">0001728117</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV81MC9mcmFnOmU3YTJlMGViN2E2YjQxY2FiNjg2MGYzOTVjZTNhZmQ2L3RhYmxlOjljZmI5ZjFmNzU2YTRmNWU4NjVmNmU5Njk1OTRmYzhmL3RhYmxlcmFuZ2U6OWNmYjlmMWY3NTZhNGY1ZTg2NWY2ZTk2OTU5NGZjOGZfMS0xLTEtMS0xNTU_69d08ea3-2542-4a1e-8fdf-131eb94ce770">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTEz_3f4b39bb-05a8-4269-8e2b-c8caa99090c0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTE1_a32a1ed4-45f1-47c5-9eaa-0080359f8e86">2020-11-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMx_524e3695-560c-4c89-bffc-50823f7726e6">GOSSAMER BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTAtMS0xLTkx_cb76d5a8-340a-46e3-be8a-dfcbd747c096">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTEtMS0xLTk0_0ef0e9a7-ffdf-4e6b-b54f-5a3618f843fd">001-38796</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmYwNTZkZjJkNDNhNDE2NjhlZjdhMTMzYzVlYWY5MjEvdGFibGVyYW5nZTpmZjA1NmRmMmQ0M2E0MTY2OGVmN2ExMzNjNWVhZjkyMV8wLTItMS0xLTk2_17187a75-63ea-423d-993c-b6a13d4b0257">47-5461709</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMy_13d79edc-86d7-4886-a730-affb7d07c04d">3013 Science Park Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTMz_d84a3887-857d-417e-8709-23fa297b9b01">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTM0_9419ca49-da9b-41d6-acaf-3b8e98a32f0c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTM2_230beacf-a443-4cab-a5a4-a969cb2eb109">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTQz_9ffdd59c-a411-4255-bd2b-037a6f4e8ec5">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTcx_b141f880-99d9-4f56-847e-63d70c633800">684-1300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6YzVlYzg3YzU2N2Q2NDNjNWE2MDJmYmUyYWU5MmM0ZGMvdGFibGVyYW5nZTpjNWVjODdjNTY3ZDY0M2M1YTYwMmZiZTJhZTkyYzRkY18wLTAtMS0xLTExNA_ead80fee-2b6c-4ccd-be8e-5bfb7a43c384">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6NmYxZjAxNzg5ODIzNDMzZWEyY2RjZDI5YTkxNDU3M2YvdGFibGVyYW5nZTo2ZjFmMDE3ODk4MjM0MzNlYTJjZGNkMjlhOTE0NTczZl8wLTAtMS0xLTExNw_8da1d166-26e7-4a93-b80a-4643a54fe7d8">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ZmZhNDY1NzA2M2E4NDY5OWFlNDI1N2IzNzEwODc4OWIvdGFibGVyYW5nZTpmZmE0NjU3MDYzYTg0Njk5YWU0MjU3YjM3MTA4Nzg5Yl8wLTAtMS0xLTEyMA_e51dbc15-7b3c-4add-997c-f387eb96906f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6YWVjMzRjZmIyNDIxNDk2YjhjYTQ2MzVmNzFlMmMyODIvdGFibGVyYW5nZTphZWMzNGNmYjI0MjE0OTZiOGNhNDYzNWY3MWUyYzI4Ml8wLTAtMS0xLTEyMw_0d85318b-b4ca-43b4-8a71-3b710a9407a7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTAtMS0xLTEyNg_0da22225-9422-4072-a428-b97ba6427892">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTItMS0xLTEyOQ_e8bffd47-81c0-4442-ba46-c09e03ea6c96">GOSS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGFibGU6ODUxMGFhNzdkM2I1NGYyYTg2ZTQ5N2VkOGIwMmJmODMvdGFibGVyYW5nZTo4NTEwYWE3N2QzYjU0ZjJhODZlNDk3ZWQ4YjAyYmY4M18xLTQtMS0xLTEzMQ_6417ba21-302f-48f5-987e-0425cac06b62">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTYw_602ed389-a88b-4fb8-9cd7-c4d5accc3e4d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i710b5edd282a4ce7b9952111589d3867_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZDc3YWUyMTEyMzRlMzZiYWM2NGY5ZTIwZjc0NDFhL3NlYzo5YWQ3N2FlMjExMjM0ZTM2YmFjNjRmOWUyMGY3NDQxYV8xL2ZyYWc6MWJmMTE0MjVkOGI1NGYxYWIxMGM0YWMyNmMxMDQ4MzkvdGV4dHJlZ2lvbjoxYmYxMTQyNWQ4YjU0ZjFhYjEwYzRhYzI2YzEwNDgzOV8xMDk5NTExNjMyMTYx_54e2884b-2212-4cb3-a4d3-b942c21983ed">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140557602731816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 10,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GOSSAMER BIO, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5461709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3013 Science Park Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">684-1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOSS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001728117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #(@6I1!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,B!:E%0D!F&
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( ,B!:E&97)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ R(%J4> "NDQ*!   R1
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( ,B!:E&#J:4#U $  #(&   -              "  8T,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ R(%J49>*NQS     $P(   L
M         ( !C X  %]R96QS+RYR96QS4$L! A0#%     @ R(%J4:K$(A8S
M 0  (@(   \              ( !=0\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( ,B!:E$D'INBK0   /@!   :              "  =40  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,B!:E%ED'F2&0$
M ,\#   3              "  ;H1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(   03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="goss-20201110.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="goss-20201110.htm">goss-20201110.htm</File>
    <File>goss-20201110.xsd</File>
    <File>goss-20201110_cal.xml</File>
    <File>goss-20201110_def.xml</File>
    <File>goss-20201110_lab.xml</File>
    <File>goss-20201110_pre.xml</File>
    <File>goss-20201110xexx991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "goss-20201110.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "goss-20201110_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "goss-20201110_def.xml"
     ]
    },
    "inline": {
     "local": [
      "goss-20201110.htm"
     ]
    },
    "labelLink": {
     "local": [
      "goss-20201110_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "goss-20201110_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "goss-20201110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "goss",
   "nsuri": "http://www.gossamerbio.com/20201110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20201110.htm",
      "contextRef": "i710b5edd282a4ce7b9952111589d3867_D20201109-20201109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.gossamerbio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20201110.htm",
      "contextRef": "i710b5edd282a4ce7b9952111589d3867_D20201109-20201109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001728117-20-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001728117-20-000008-xbrl.zip
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M._RP7[OFQ-X,_NMG4;C[_U!+ P04    " #(@6I1OMVYYH4"  " "0  $0
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M-WDP^507,'KH%:A@L2'OWGJ[^ E02P,$%     @ R(%J46*JU>H% @  <08
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MP4 I6_R:IQD;C"NESEKJK\Y*K&/4.KE<>SSW.'L8UN/X=6)TNUK5"N;#3O1
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M0*]P#!8>&1W&P(3KF2^7<+2Y?[-X(MX)73C8N?NB>^G^=^-@YR]02P,$%
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MJ>>#\([&C @;[QZ-0P&_@UQ7 7M]=O#[8R#I:6G7KK=;&DN7UXJ%*H:-&0
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MN$[H 4K@I2XXFK"KD&LKQE&@9Q+S)!H#%AW"WK^!^^YK1ZYFA'5P7\S!/+F
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MF0/KF=)HVLA=MJ-5%7<<= :1D[$J3?1!FG-'>NCN4;%T'[4H=D&0903W#=)
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M*W<,/T:)[[W[?U!+ 0(4 Q0    ( ,B!:E$S_,I@K14  /"B   1
M      "  0    !G;W-S+3(P,C Q,3$P+FAT;5!+ 0(4 Q0    ( ,B!:E&^
MW;GFA0(  ( )   1              "  =P5  !G;W-S+3(P,C Q,3$P+GAS
M9%!+ 0(4 Q0    ( ,B!:E'7-=] @@$  ,P"   5              "  9 8
M  !G;W-S+3(P,C Q,3$P7V-A;"YX;6Q02P$"% ,4    " #(@6I18JK5Z@4"
M  !Q!@  %0              @ %%&@  9V]S<RTR,#(P,3$Q,%]D968N>&UL
M4$L! A0#%     @ R(%J43;.2%2="@  CV$  !4              ( !?1P
M &=O<W,M,C R,#$Q,3!?;&%B+GAM;%!+ 0(4 Q0    ( ,B!:E&!.XO-X08
M (DS   5              "  4TG  !G;W-S+3(P,C Q,3$P7W!R92YX;6Q0
M2P$"% ,4    " #(@6I149F:,/L;  "M\   &               @ %A+@
M9V]S<RTR,#(P,3$Q,'AE>'@Y.3$N:'1M4$L%!@     '  < T $  ))*
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
